Friday, December 16, 2022

Adults Treated for ADHD

 From Mad in America:

New research published in Current Medical Research and Opinions studied the impact of symptoms and the adverse effects of medication on adults receiving treatment for ADHD. The results of this study suggest that adults who are diagnosed with ADHD and taking medication often experience side effects and symptoms that substantially reduce their quality of life. For example, the researchers found evidence of reduced well-being, increased unemployment, mood issues, and insomnia.

It appears that the study was produced by employees and consultants for the pharmaceutical company Otsuka, which is currently developing and promoting its own drug for ADHD, Centanafadine. As such, the company may benefit from research that shines a light on the failures and adverse effects of current treatments for ADHD. The authors from Otsuka frame the study this way:
[Previous] studies illustrate that emotional symptoms can hurt the quality of life in adults with ADHD. The current study extends these findings by evaluating the impact of the most common symptoms associated with ADHD/treatment-related adverse side effects on the daily living of adults with ADHD and quantifying the burden exerted by these symptoms. Considering that all symptoms in this study were captured over the month prior to data collection, the impact of symptoms described herein may represent only the tip of the iceberg in regard to the real burden experienced by patients over their ADHD journey, which often lasts for several years or even over the entire lifespan for some.
(Read more.)
Share

No comments: